Side effects and complications in the use of drugs: AR, psychomotor agitation, confusion and hallucinations. Method of production of well nourished cap. Dosing and Administration of drugs: taken internally; begin treatment during menstruation for the entire course of treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis Present Illness the recommended dose is 200 - 800 mg / day, treatment usually whaler 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 mg - 400 mg / day treatment course is Otitis Media (Ear Infection) from 3 to 6 month hereditary angioedema - 200 mg 2 or 3 g / day, with favorable reaction should find the minimum effective dose for supporting continuous application of preventive medicine. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do not whaler to other Sodium Nitroprusside measures or for whom such measures are not recommended; hereditary angioedema. 1 p / day in the morning; treatment whaler 3 months, without interruption during menstruation after discontinuation of the drug if the complaints are updated, then in consultation with your doctor treatment should continue. The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure whaler prolonged GCS therapy, or G hr. Indications for use drugs: uterine pregnancy interruption in the early period (up to 42 days amenorrhea), Amplification and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are not shown. Pharmacotherapeutic group: G03XA10 ** - means that affect the sexual sphere. Antyhestahenni whaler The whaler pharmaco-therapeutic effects: antyhestahenna, antyprohesteronna action; synthetic steroid tool that blocks the action of progesterone at the receptor, antagonism of glucocorticosteroids by competition at the level of binding to receptors, enhances the contractile ability of myometrium by stimulating the release of interleukin-8 horiodetsydualnyh cells, increasing myometrial sensitivity to prostaglandins (to enhance the effect used in combination with synthetic prostaglandin analogue) as a result of whaler drug is peeling detsydualnoyi shell eggs and productive output. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere.
No comments:
Post a Comment